Lo Francis's Form 4 filing
Adaptive Biotechnologies Corp (ADPT) · filed Jun 8, 2026
- Accession no.
- 0001780660-26-000015
- Filed
- Jun 8, 2026
- Trade date
- Jun 4, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $695.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lo FrancisCIK 0001780660 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | MOption exerciseAcquired | +5,792 | $12.14 | +$70,314.88 | 276,946 | Direct | |
| Jun 4, 2026 | Common Stock | MOption exerciseAcquired | +2,009 | $8.46 | +$16,996.14 | 278,955 | Direct | |
| Jun 4, 2026 | Common Stock | MOption exerciseAcquired | +2,344 | $3.99 | +$9,352.56 | 281,299 | Direct | |
| Jun 4, 2026 | Common Stock | MOption exerciseAcquired | +9,376 | $8.12 | +$76,133.12 | 290,675 | Direct | |
| Jun 4, 2026 | Common Stock | SSaleDisposed | −39,741 | $17.49 | −$695,070.09 | 250,934 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | MOption exerciseDisposed | −5,792 | $0.00 | $0 | 171,823 | Direct | |
| Jun 4, 2026 | Common Stock | MOption exerciseDisposed | −2,009 | $0.00 | $0 | 85,065 | Direct | |
| Jun 4, 2026 | Common Stock | MOption exerciseDisposed | −2,344 | $0.00 | $0 | 85,953 | Direct | |
| Jun 4, 2026 | Common Stock | MOption exerciseDisposed | −9,376 | $0.00 | $0 | 140,648 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.